1466.Tw

The company's capital structure is characterized by a debt-to-equity ratio of 1.02, indicating a relatively balanced mix of debt and equity financing. However, the company's liquidity position is assessed as medium, with a current ratio of 3.49. Despite having cash and equivalents of TWD 200 million, the company's free cash flow is negative at TWD -25.18 million, and operating cash flow is TWD 278.22 million.

Profitability metrics show significant underperformance relative to industry norms. The company reported a net loss of TWD -119.03 million and an operating loss of TWD -100.01 million. Return on equity is -7.7%, and return on assets is -3.23%, both well below the typical performance of companies in the specialty chemicals industry.

The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and market-specific risks.

The company's growth trajectory is negative, with a net loss in the most recent reporting period. Historical revenue data is not provided, but the current financial performance suggests a challenging outlook for the near term.

Key risk factors include the company's negative net cash position after subtracting total debt, which could constrain operational flexibility. The risk assessment indicates a low probability of dilution, but the company's operating losses and negative free cash flow suggest potential for future capital-raising activities.

Recent events include the filing of financial results showing a net loss and operating loss. No recent transcripts or additional filings are disclosed in the available data.